Skip to main content

Search

Analysis on this artifact

abanelleloo.hk11

I think that this is interestingly written and an interesting comparison between your own experiences in Singapore and the Naluwan grandma. What do you think can be applied to your final piece of work from this fieldnote? Do you think that your experiences in Singapore has shaped you to think differently and feel differently from an Amis person living in Naluwan?

Fieldnote_ 0415_Naluwan_Annabelle

This Saturday was truly an unforgettable experience – I felt like the past few times that I've gone to the tribe were on a more superficial level since we only got to chat with the Ahmas for very s

Fieldnote_0329_Naluwan_ANNABELLE

We sat in groups with some elderly from the Amis tribe in the activity center, and I had the opportunity to sit with a pair of sisters and their close friend.

pece_annotation_1473350972

wolmad
Annotation of

The Red Cross opened a Red Cross R&D in 1961 to further existing research on blood component technology, blood safety, plasma-derived therapeutics, transfusion medicine, and biomedical science. Red Cross R&D has made accievements in the following areas, listed on their website:

  • Developed a technique to freeze red blood cells, preserving their viability for up to 3 years, helping to ensure a steady supply of red cells for patients needing rare blood types. (1971)
  • Contributed to the development of bar-coding for blood products. (1977)
  • Developed procedures for large-scale purification of therapeutic blood proteins like gamma globulin and factor VIII. (1978)
  • Collaborated with scientists at the Centers for Disease Control and Prevention (CDC) to define the window period—the length of time between infection with the virus and the earliest stage in infection that can be detected by a test—for human immunodeficiency virus (HIV) following implementation of universal HIV testing of donor blood. (1994)
  • Investigated the prevalence of blood-transmitted diseases like human T-lymphotropic virus-1 (HTLV-1) and Chagas disease, providing key data that led to implementation of testing for these diseases. (HTLV-1 in 1987, Chagas disease in 2008)
  • Continue to facilitate improvements in bacterial testing of blood products.
  • Investigated the role of antibodies in female-source plasma in causing transfusion-related acute lung injury (TRALI), leading to reduction in the incidence of TRALI by providing male-predominant plasma for transfusion. (2009)
  • Modified height and weight restrictions for donors younger than 19, which has significantly reduced adverse reactions among young donors. (2009)

pece_annotation_1480177143

wolmad

Based on this article's bibliography, it appears that a large ammount of information from this article was drawn from MSF reports and essays, United Nations reports, and previous scholarly research done in the fields of humanitarianism, feminism, and the social aspects of medicine.